Table 4.
Variable | Patients of COVID-19 with pancreatitis | Patients of COVID-19 with elevatedpancreatic enzymes(N = 29) | Patients of COVID-19 without elevated enzymes (N = 23) | P | |||
---|---|---|---|---|---|---|---|
P1 | P2 | P3 | Overall | ||||
Hospital treatment, n(%) | |||||||
Corticosteroid | N | Y | Y | 2(66.7) | 14(48.3) | 11(47.8) | 1 |
Immunoglobulin | Y | N | Y | 2(66.7) | 10(34.5) | 5(21.7) | 0.23 |
Antibiotics | Y | Y | Y | 3(100) | 29(100) | 23(100) | - |
Mechanical Ventilation | N | Y | Y | 3(100) | 21(72.4) | 7(30.4) | 0.002 |
CRRT | N | Y | Y | 2(66.7) | 13(44.8) | 2(8.7) | 0.003 |
CRRT, continuous renal replacement therapy.